Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 6/2012

01.06.2012 | Rapid Communication

GDF3 inhibits the growth of breast cancer cells and promotes the apoptosis induced by Taxol

verfasst von: Qiang Li, Yichen Ling, Long Yu

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study is to investigate whether GDF3 is related to the progression of human breast cancer and the effects of GDF3 on breast cancer cells.

Methods

The expression of GDF3 in 24 breast cancer specimens paired with corresponding neighboring nontumorous tissue was studied by Western blot. Breast cancer cells were treated with different concentrations of recombinant human GDF3 protein. Using lentivirus containing sh-RNA, we knocked down the expression of GDF3. Soft agar assay was performed to explore the effects of GDF3 on colony formation. Different anti-tumor drugs dealt with MCF-7 cells stably expressing GDF3.

Results

We found that GDF3 expression level was significantly down-regulated in breast cancer tissues compared to the surrounding nontumorous tissues. GDF3 proteins could inhibit the proliferation of MCF-7 and T47D cells. We also found that the knockdown of GDF3 resulted in the promotion of colony formation and enhanced the ability of anchorage-independent cell growth in soft agar. Furthermore, overexpression of GDF3 could promote the apoptosis induced by Taxol.

Conclusions

Our data indicated that GDF3 expression is significantly decreased in human breast cancer tissues, and reconstitution of GDF3 in breast cancer may be a potential therapeutic approach to inhibit aggressive growth of breast cancer.
Literatur
Zurück zum Zitat Ananth S, Knebelmann B, Gruning W, Dhanabal M, Walz G, Stillman IE, Sukhatme VP (1999) Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma. Cancer Res 59:2210–2216PubMed Ananth S, Knebelmann B, Gruning W, Dhanabal M, Walz G, Stillman IE, Sukhatme VP (1999) Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma. Cancer Res 59:2210–2216PubMed
Zurück zum Zitat Andersson O, Bertolino P, Ibáñez CF (2007) Distinct and cooperative roles of mammalian Vg1 homologs GDF1 and GDF3 during early embryonic development. Dev Biol 11:500–511CrossRef Andersson O, Bertolino P, Ibáñez CF (2007) Distinct and cooperative roles of mammalian Vg1 homologs GDF1 and GDF3 during early embryonic development. Dev Biol 11:500–511CrossRef
Zurück zum Zitat Andersson O, Korach-Andre M, Reissmann E, Ibáñez CF, Bertolino P (2008) Growth/differentiation factor 3 signals through ALK7 and regulates accumulation of adipose tissue and diet-induced obesity. Proc Natl Acad Sci USA 105:7252–7256PubMedCrossRef Andersson O, Korach-Andre M, Reissmann E, Ibáñez CF, Bertolino P (2008) Growth/differentiation factor 3 signals through ALK7 and regulates accumulation of adipose tissue and diet-induced obesity. Proc Natl Acad Sci USA 105:7252–7256PubMedCrossRef
Zurück zum Zitat Bikfalvi A (1995) Significance of angiogenesis in tumour progression and metastasis. Eur J Cancer 31:1101–1104CrossRef Bikfalvi A (1995) Significance of angiogenesis in tumour progression and metastasis. Eur J Cancer 31:1101–1104CrossRef
Zurück zum Zitat Caricasole AA, van Schaik RH, Zeinstra LM, Wierikx CD, van Gurp RJ, van den Pol M, Looijenga LH, Oosterhuis JW, Pera MF, Ward A, de Bruijn D, Kramer P, de Jong FH, van den Eijnden-van Raaij AJ (1998) Human growth-differentiation factor 3 (hGDF3): developmental regulation in human teratocarcinoma cell lines and expression in primary testicular germ cell tumours. Oncogene 16:95–103PubMedCrossRef Caricasole AA, van Schaik RH, Zeinstra LM, Wierikx CD, van Gurp RJ, van den Pol M, Looijenga LH, Oosterhuis JW, Pera MF, Ward A, de Bruijn D, Kramer P, de Jong FH, van den Eijnden-van Raaij AJ (1998) Human growth-differentiation factor 3 (hGDF3): developmental regulation in human teratocarcinoma cell lines and expression in primary testicular germ cell tumours. Oncogene 16:95–103PubMedCrossRef
Zurück zum Zitat Chen C, Ware SM, Sato A, Houston-Hawkins DE, Habas R, Matzuk MM, Shen MM, Brown CW (2006) The Vg1-related protein Gdf3 acts in a Nodal signaling pathway in the pre-gastrulation mouse embryo. Development 133:319–329PubMedCrossRef Chen C, Ware SM, Sato A, Houston-Hawkins DE, Habas R, Matzuk MM, Shen MM, Brown CW (2006) The Vg1-related protein Gdf3 acts in a Nodal signaling pathway in the pre-gastrulation mouse embryo. Development 133:319–329PubMedCrossRef
Zurück zum Zitat Chin D, Boyle GM, Parsons PG, Coman WB (2004) What is transforming growth factor-beta (TGF-beta). Br J Plast Surg 57:215–221PubMedCrossRef Chin D, Boyle GM, Parsons PG, Coman WB (2004) What is transforming growth factor-beta (TGF-beta). Br J Plast Surg 57:215–221PubMedCrossRef
Zurück zum Zitat Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577–584PubMedCrossRef Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577–584PubMedCrossRef
Zurück zum Zitat Desruisseau S, Ghazarossian-Ragni E, Chinot O, Martin PM (1996) Divergent effect of TGF-beta1 on growth and proteolytic modulation of human prostatic-cancer cell lines. Int J Cancer 66:796–801PubMedCrossRef Desruisseau S, Ghazarossian-Ragni E, Chinot O, Martin PM (1996) Divergent effect of TGF-beta1 on growth and proteolytic modulation of human prostatic-cancer cell lines. Int J Cancer 66:796–801PubMedCrossRef
Zurück zum Zitat Duhagon MA, Hurt EM, Sotelo-Silveira JR, Zhang X, Farrar WL (2010) Genomic profiling of tumor initiating prostatospheres. BMC Genomics 11:324PubMedCrossRef Duhagon MA, Hurt EM, Sotelo-Silveira JR, Zhang X, Farrar WL (2010) Genomic profiling of tumor initiating prostatospheres. BMC Genomics 11:324PubMedCrossRef
Zurück zum Zitat Elliott RL, Blobe GC (2005) Role of transforming growth factor beta in human cancer. J Clin Oncol 23:2078–2093PubMedCrossRef Elliott RL, Blobe GC (2005) Role of transforming growth factor beta in human cancer. J Clin Oncol 23:2078–2093PubMedCrossRef
Zurück zum Zitat Ezeh UI, Turek PJ, Reijo RA, Clark AT (2005) Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 10:2255–2265CrossRef Ezeh UI, Turek PJ, Reijo RA, Clark AT (2005) Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 10:2255–2265CrossRef
Zurück zum Zitat Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE (1996) DPC4, a candidate tumor suppressor gene athuman chromosome 18q21.1. Science 271:350–353PubMedCrossRef Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE (1996) DPC4, a candidate tumor suppressor gene athuman chromosome 18q21.1. Science 271:350–353PubMedCrossRef
Zurück zum Zitat Herpin A, Lelong C, Favrel P (2004) Transforming growth factor-beta-related proteins: an ancestral and widespread superfamily of cytokines in metazoans. Dev Comp Immunol 28:461–485PubMedCrossRef Herpin A, Lelong C, Favrel P (2004) Transforming growth factor-beta-related proteins: an ancestral and widespread superfamily of cytokines in metazoans. Dev Comp Immunol 28:461–485PubMedCrossRef
Zurück zum Zitat Katakura Y, Nakata E, Miura T, Shirahata S (1999) Transforming growth factor beta triggers two independent-senescence programs in cancer cells. Biochem Biophys Res Commun 255:110–115PubMedCrossRef Katakura Y, Nakata E, Miura T, Shirahata S (1999) Transforming growth factor beta triggers two independent-senescence programs in cancer cells. Biochem Biophys Res Commun 255:110–115PubMedCrossRef
Zurück zum Zitat Levine AJ, Brivanlou AH (2006) GDF3, a BMP inhibitor, regulates cell fate in stem cells and early embryos. Development 133:209–216PubMedCrossRef Levine AJ, Brivanlou AH (2006) GDF3, a BMP inhibitor, regulates cell fate in stem cells and early embryos. Development 133:209–216PubMedCrossRef
Zurück zum Zitat Li Q, An J, Liu X, Zhang M, Ling Y, Wang C, Zhao J, Yu L (2012a) SNIP1: a new activator of HSE signaling pathway. Mol Cell Biochem 362:1–6PubMedCrossRef Li Q, An J, Liu X, Zhang M, Ling Y, Wang C, Zhao J, Yu L (2012a) SNIP1: a new activator of HSE signaling pathway. Mol Cell Biochem 362:1–6PubMedCrossRef
Zurück zum Zitat Li Q, Liu X, Wu Y, An J, Hexige S, Ling Y, Zhang M, Yang X, Yu L (2012b) The conditioned medium from a stable human GDF3-expressing CHO cell line, induces the differentiation of PC12 cells. Mol Cell Biochem 359:115–123PubMedCrossRef Li Q, Liu X, Wu Y, An J, Hexige S, Ling Y, Zhang M, Yang X, Yu L (2012b) The conditioned medium from a stable human GDF3-expressing CHO cell line, induces the differentiation of PC12 cells. Mol Cell Biochem 359:115–123PubMedCrossRef
Zurück zum Zitat Massague J, Heino J, Laiho M (1991) Mechanisms in TGF-beta action. Ciba Found Symp 157:51–59PubMed Massague J, Heino J, Laiho M (1991) Mechanisms in TGF-beta action. Ciba Found Symp 157:51–59PubMed
Zurück zum Zitat Massague J, Cheifetz S, Laiho M, Ralph DA, Weis FM, Zentella A (1992) Transforming growth factor-beta. Cancer Surv 12:81–103PubMed Massague J, Cheifetz S, Laiho M, Ralph DA, Weis FM, Zentella A (1992) Transforming growth factor-beta. Cancer Surv 12:81–103PubMed
Zurück zum Zitat Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K (2002) Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 7:1191–1204PubMedCrossRef Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K (2002) Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 7:1191–1204PubMedCrossRef
Zurück zum Zitat Perry RR, Kang Y, Greaves BR (1995) Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells. Br J Cancer 72:1441–1446PubMedCrossRef Perry RR, Kang Y, Greaves BR (1995) Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells. Br J Cancer 72:1441–1446PubMedCrossRef
Zurück zum Zitat Shen JJ, Huang L, Li L, Jorgez C, Matzuk MM, Brown CW (2009) Deficiency of growth differentiation factor 3 protects against diet-induced obesity by selectively acting on white adipose. Mol Endocrinol 23:113–123PubMedCrossRef Shen JJ, Huang L, Li L, Jorgez C, Matzuk MM, Brown CW (2009) Deficiency of growth differentiation factor 3 protects against diet-induced obesity by selectively acting on white adipose. Mol Endocrinol 23:113–123PubMedCrossRef
Zurück zum Zitat Torre-Amione G, Beauchamp RD, Koeppen H, Park BH, Schreiber H, Moses HL, Rowley DA (1990) A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Proc Natl Acad Sci USA 87:1486–1490PubMedCrossRef Torre-Amione G, Beauchamp RD, Koeppen H, Park BH, Schreiber H, Moses HL, Rowley DA (1990) A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Proc Natl Acad Sci USA 87:1486–1490PubMedCrossRef
Zurück zum Zitat Wang W, Yang Y, Meng Y, Shi Y (2004) GDF-3 is an adipogenic cytokine under high fat dietary condition. Biochem Biophys Res Commun 321:1024–1031PubMedCrossRef Wang W, Yang Y, Meng Y, Shi Y (2004) GDF-3 is an adipogenic cytokine under high fat dietary condition. Biochem Biophys Res Commun 321:1024–1031PubMedCrossRef
Zurück zum Zitat Yan Z, Deng X, Friedman E (2001) OncogenicKi-ras confers a more aggressive colon cancer phenotype through modification of transforming growth factor-beta receptor III. J Biol Chem 276:1555–1563PubMedCrossRef Yan Z, Deng X, Friedman E (2001) OncogenicKi-ras confers a more aggressive colon cancer phenotype through modification of transforming growth factor-beta receptor III. J Biol Chem 276:1555–1563PubMedCrossRef
Zurück zum Zitat Yingling JM, Blanchard KL, Sawyer JS (2004) Development of TGF-beta signalling inhibitors for cancer therapy. Nat Rev Drug Discov 3:1011–1022PubMedCrossRef Yingling JM, Blanchard KL, Sawyer JS (2004) Development of TGF-beta signalling inhibitors for cancer therapy. Nat Rev Drug Discov 3:1011–1022PubMedCrossRef
Metadaten
Titel
GDF3 inhibits the growth of breast cancer cells and promotes the apoptosis induced by Taxol
verfasst von
Qiang Li
Yichen Ling
Long Yu
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 6/2012
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-012-1213-3

Weitere Artikel der Ausgabe 6/2012

Journal of Cancer Research and Clinical Oncology 6/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.